NetworkNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Launches “Rainbow Dreams” – A New Line of Flavored CBD & THC Oil Infused Vaporization CCell Cartridges

August 5, 2019 09:05:14

California-based Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 (OTCQB: IGNG), this morning announced the launch of its unique line of newly formulated and flavored cannabis oil infused CDB and THC vaporization cartridges branded as “Rainbow Dreams.” According to the update, the new product line includes a formulated CBD heavy 3:1 vaporization cartridge for customers that need pain relief but prefer minimal THC impact. Each of the four new Grapefruit Rainbow Dream vape cartridges will have its own unique flavor profile, from mango passion to citrus bliss, paired to a complimentary cannabis strain including Durban Poison, Cannatonic and OG Kush. “Moving the Rainbow Dreams project forward demonstrates our team’s ability to bring a high quality product to market at a competitive price with solid margins for Grapefruit and its retailers. Flavored and full spectrum cannabis oils, including live resin are growing in popularity in California and elsewhere because customers in the recreational market want a no burn-flavored oil without any offending cannabis smell,” IGNG/Grapefruit CEO Bradley J. Yourist said in the news release. “Our Rainbow Dreams products deliver on this. Grapefruit, among its many other abilities has the expertise to formulate such flavored and infused oils to meet our customer’s current demands.  It is our experience that some customers like a more CBD and CBN heavy formulated oil for help with pain and sleep and are not interested in becoming maximally affected in some cases. Our 3:1 CBD vaporization carts, with a mango passion flavor profile, fill that ever growing demand for CBD heavy products. We also have a day-time sativa blended oil for those recreational users that have an active lifestyle.”

To view the full press release, visit

About Grapefruit Boulevard Investments Inc.

Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 Inc. (OTCQB: IGNG), holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s cannabis and CBD extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 10 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January of 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis and CBD product company. For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office